Madrigal Pharmaceuticals (MDGL) had the highest return between December 1, 2022 and December 30, 2022 by a mid-cap US stock, returning 311%.
| ASSET | DATE | % RETURN |
|---|---|---|
Madrigal Pharmaceuticals (MDGL) | 12/1/2022 - 12/30/2022 | 311% |
Viking Therapeutics (VKTX) | 12/1/2022 - 12/30/2022 | 131.53% |
Verona Pharma PLC ADR (VRNA) | 12/1/2022 - 12/30/2022 | 101.62% |
Avidity Biosciences (RNA) | 12/1/2022 - 12/30/2022 | 90.47% |
iQIYI (IQ) | 12/1/2022 - 12/30/2022 | 82.76% |
Soleno Therapeutics (SLNO) | 12/1/2022 - 12/30/2022 | 59.68% |
Celcuity LLC (CELC) | 12/1/2022 - 12/30/2022 | 57.77% |
Arcellx (ACLX) | 12/1/2022 - 12/30/2022 | 55.44% |
Alvotech (ALVO) | 12/1/2022 - 12/30/2022 | 53.85% |
Bilibili (BILI) | 12/1/2022 - 12/30/2022 | 42.2% |
Roivant Sciences (ROIV) | 12/1/2022 - 12/30/2022 | 38.96% |
GDS (GDS) | 12/1/2022 - 12/30/2022 | 38.86% |
Protagonist Therapeutics (PTGX) | 12/1/2022 - 12/30/2022 | 37.75% |
Melco Resorts & Entertainment (MLCO) | 12/1/2022 - 12/30/2022 | 37.23% |
SoundHound AI (SOUN) | 12/1/2022 - 12/30/2022 | 37.21% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 12/1/2022 - 12/30/2022 | 37.11% |
Immunovant (IMVT) | 12/1/2022 - 12/30/2022 | 35.29% |
Global Business Travel (GBTG) | 12/1/2022 - 12/30/2022 | 35% |
TG Therapeutics (TGTX) | 12/1/2022 - 12/30/2022 | 33.22% |
Powell Industries (POWL) | 12/1/2022 - 12/30/2022 | 32.81% |
360 DigiTech (QFIN) | 12/1/2022 - 12/30/2022 | 30.87% |
Kingsoft Cloud Holdings (KC) | 12/1/2022 - 12/30/2022 | 28.09% |
Vipshop (VIPS) | 12/1/2022 - 12/30/2022 | 27.6% |
Ultragenyx (RARE) | 12/1/2022 - 12/30/2022 | 26.69% |
Liquidia Technologies (LQDA) | 12/1/2022 - 12/30/2022 | 26.14% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
